Tendências de uso e prescrição de Benzodiazepínicos na atenção primária do SUS: um estudo em Massaranduba – PB
Article Sidebar
Main Article Content
Abstract
Psychotropics are substances that will act on the Central Nervous System, where they will cause changes in behavior and mood in the user. With regard to benzodiazepines (BZDs), these are indicated as the first treatment option for patients who experience anxiety and/or insomnia. Despite being safe and highly efficient drugs, their long-term use is not recommended because it can generate adverse effects such as cognitive, physical, psychomotor effects, tolerance and even generate high dependence on this substance. Therefore, this research aimed to evaluate the use of benzodiazepines in the SUS primary care service in the Municipality of Massaranduba – PB. The research was conducted in a basic pharmacy in that municipality, using the pharmacy system and list B1 prescriptions from June 2022 to June 2023 as a source of information, in order to draw up a profile of the use of BZDs. Regarding the results, there was a prevalence of females in the BZDs prescriptions analyzed, with clonazepam 2 mg being the most prescribed medication. It was observed that 32.3% of patients treated used this medication, exceeding the period of use recommended in the literature. Although scientific findings indicate that diazepam should not be combined with amitriptyline or fluoxetine, we still found a percentage of 11% of prescriptions with this association.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
• The author (s) warrant that the contribution is original and unpublished and that it is not in the process of being evaluated in other journal (s);
• The journal is not responsible for the opinions, ideas and concepts issued in the texts, as they are the sole responsibility of the author (s);
• Publishers have the right to make textual adjustments and to adapt the article to the rules of publication.
Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg publish in institutional repository or as book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of the published work (See The Effect of Free Access) at http://opcit.eprints.org/oacitation-biblio.html
